109th annual conference of the german society for pathology​

Comprehensive Genomic Profiling (CGP) is redefining standard of care in precision oncology enabling nucleotide-level resolution of a tumor’s complete genomic landscape in a single comprehensive assay. Unlike iterative multiple single-gene tests, FISH-PCR-single gene or small hotspot panels, CGP uses advanced technologies such as next-generation sequencing to detect a broad range of genetic alterations, including mutations, copy number changes, structural variants and large genomic signatures (TMB, MSI, HRD).

From early detection to treatment monitoring, see how Illumina genomic solutions improve cancer outcomes. Visit us at Illumina booth 33106.

Liquid biopsy CGP explored across three expert-led webinars—from clinical evidence to large-panel implementation at Mayo Clinic.